Novo Nordisk has announced a sweeping reduction in the cost of its blockbuster diabetes drug Ozempic, cutting the monthly ...

BlueStone Jewellery & Lifestyle shares debuted negatively at ₹510 on NSE, down 1.35% from its IPO price. The ₹1,540.65 crore ...

The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Star Imaging shares debuted at ₹142 on BSE SME, matching its issue price. The ₹69.47 crore IPO saw 5.67 times subscription, ...

BlueStone’s IPO comprised a fresh issue worth up to INR 1,000 Cr along with an OFS of up to 2.4 Cr shares by existing ...

Shares of Bluestone Jewellery listed at ₹508.80 on the BSE, down 1.59% from the IPO price of ₹517, with a market ...

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

BlueStone Jewellery shares debuted with a slight discount, opening at Rs 510 on NSE and Rs 508.80 on BSE, against an IPO ...

The Washington Commanders activated wide receiver Terry McLaurin from the PUP list over the weekend and want him at practice ...

While home sales have slowed, prices are still rising, which could indicate buyers are still willing to pay list prices or close to them for homes in the D.C. market.

Shares of Icodex Publishing Solutions were off to a weak start as they listed on the BSE SME platform at a 20% discount to ...